Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasiglucagon for Hypoglycemia Rescue in T1DM
NCT03378635Phase 3Completed
- Sponsor
- Zealand Pharma
- Start
- Dec 2017
- Primary completion
- Apr 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of dasiglucagon in hypoglycemia, sponsored by Zealand Pharma. Started Dec 2017; status: completed.
02
Drugs
dasiglucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT03378635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03378635.